Advanced Enzyme Technologies Limited
NSE: ADVENZYMES BSE: ADVENZYMES
NSE
300.95
-5.15 (-1.68%)
Prev Close
306.1
Open Price
303.6
Volume
68,058
Today Low / High
297.1 / 305
52 WK Low / High
257.9 / 366.25
Range
286 - 316
BSE
300.45
-5.30 (-1.73%)
Prev Close
305.75
Open Price
301
Volume
5,249
Today Low / High
297.3 / 302.35
52 WK Low / High
257.85 / 366.55
Range
285 - 315
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 300.95 (target range: 286 - 316), reflecting a change of -5.15 (-1.68246%). On the BSE, it is listed at 300.45 (target range: 285 - 315), showing a change of -5.3 (-1.73344%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
13 Feb
303.60
-0.87%
12 Feb
309.10
-0.97%
11 Feb
299.85
3.79%
10 Feb
290.70
2.79%
09 Feb
292.00
-0.14%
06 Feb
289.25
-0.62%
05 Feb
291.85
-0.22%
04 Feb
283.25
3.04%
03 Feb
285.60
0.04%
02 Feb
273.00
-2.64%
01 Feb
289.00
-5.88%
30 Jan
293.65
1.07%
29 Jan
279.70
6.58%
28 Jan
270.00
3.80%
27 Jan
265.00
0.57%
23 Jan
272.20
-1.40%
22 Jan
275.00
-1.11%
21 Jan
266.00
2.48%
20 Jan
276.05
-1.97%
19 Jan
275.00
0.20%
16 Jan
282.20
-2.07%
Advanced Enzyme Technologies Limited Graph
Advanced Enzyme Technologies Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Advanced Enzyme Technologies Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 300.95, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 300.45 | 303.45 | 273.11 - 333.80 |
| 306.46 | 245.17 - 367.75 | ||
| 309.46 | 216.62 - 402.30 | ||
| Bearish Scenario | 300.45 | 297.45 | 267.70 - 327.19 |
| 294.44 | 235.55 - 353.33 | ||
| 291.44 | 204.01 - 378.87 |
Overview of Advanced Enzyme Technologies Limited
ISIN
INE837H01020
Industry
Chemicals - Specialty
Vol.Avg
146,212
Market Cap
33,684,370,460
Last Dividend
5.2
Official Website
IPO Date
2016-08-01
DCF Diff
-596.39
DCF
902
Financial Ratios Every Investor Needs
Stock Dividend of ADVENZYMES
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-07-23 | July 23, 25 | 1.2 | 1.2 | 2025-07-23 | 2025-08-05 | |
| 2025-05-16 | May 16, 25 | 4 | 4 | 2025-05-17 | 2025-06-10 | |
| 2024-07-18 | July 18, 24 | 1.1 | 1.1 | 2024-07-18 | 2024-08-24 | |
| 2024-05-17 | May 17, 24 | 4 | 4 | 2024-05-18 | 2024-06-05 | |
| 2023-08-04 | August 04, 23 | 1 | 1 | 2023-08-05 | 2023-09-11 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 636.91 Cr | 329.96 Cr | 306.95 Cr | 0.4819 | 0.88 Cr | 20.89 Cr | 157.88 Cr | 131.12 Cr | 11.70 | 227.48 Cr | 0.2059 |
| 2024-03-31 | 623.48 Cr | 159.41 Cr | 464.07 Cr | 0.7443 | 21.67 Cr | 24.07 Cr | 172.83 Cr | 133.31 Cr | 11.92 | 227.18 Cr | 0.2138 |
| 2023-03-31 | 540.64 Cr | 131.80 Cr | 397.61 Cr | 0.7355 | 21.66 Cr | 21.83 Cr | 129.69 Cr | 105.64 Cr | 9.45 | 178.90 Cr | 0.1954 |
| 2022-03-31 | 528.90 Cr | 119.43 Cr | 409.47 Cr | 0.7742 | 19.37 Cr | 20.72 Cr | 171.01 Cr | 119.58 Cr | 10.70 | 209.00 Cr | 0.2261 |
| 2021-03-31 | 500.45 Cr | 105.59 Cr | 394.85 Cr | 0.7890 | 15.51 Cr | 15.83 Cr | 290.85 Cr | 145.93 Cr | 13.07 | 241.42 Cr | 0.2916 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 107.69 Cr | 1,621.35 Cr | 152.68 Cr | 1,420.8630 Cr | 39.35 Cr | -68.34 Cr | 157.31 Cr | 314.63 Cr | 0.00 Cr | 0.00 Cr | 10.05 Cr | 96.7550 Cr |
| 2024-03-31 | 113.75 Cr | 1,535.46 Cr | 164.38 Cr | 1,324.1280 Cr | 47.31 Cr | -66.44 Cr | 148.46 Cr | 307.27 Cr | 8.93 Cr | 0.00 Cr | -26.98 Cr | 106.3570 Cr |
| 2023-03-31 | 96.42 Cr | 1,421.85 Cr | 137.68 Cr | 1,235.0690 Cr | 33.50 Cr | -62.92 Cr | 123.99 Cr | 288.82 Cr | 31.70 Cr | 7.78 Cr | 0.17 Cr | 77.5660 Cr |
| 2022-03-31 | 267.36 Cr | 1,267.61 Cr | 127.22 Cr | 1,088.5930 Cr | 34.73 Cr | -232.63 Cr | 120.92 Cr | 271.88 Cr | 24.50 Cr | 8.42 Cr | 0.07 Cr | 60.4220 Cr |
| 2021-03-31 | 191.92 Cr | 1,152.67 Cr | 121.90 Cr | 970.6560 Cr | 27.96 Cr | -164.30 Cr | 93.88 Cr | 243.24 Cr | 9.47 Cr | 1.36 Cr | 0.07 Cr | 67.5580 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 149.0980 Cr | -99.0440 Cr | -69.2020 Cr | 115.2900 Cr | -19.5240 Cr | 94.2250 Cr | -34.7810 Cr | 131.1150 Cr | -3.5780 Cr | -59.0300 Cr | -7.7970 Cr |
| 2024-03-31 | 141.3690 Cr | -64.6490 Cr | -59.2380 Cr | 99.0560 Cr | 17.3310 Cr | 113.7510 Cr | -42.3130 Cr | 133.3050 Cr | 12.0550 Cr | -56.7120 Cr | -23.8340 Cr |
| 2023-03-31 | 140.3620 Cr | -298.1810 Cr | -25.7980 Cr | 102.1810 Cr | -170.9350 Cr | 96.4200 Cr | -38.1810 Cr | 140.3880 Cr | 2.3000 Cr | -12.5420 Cr | 0.7550 Cr |
| 2022-03-31 | 122.2910 Cr | -24.9120 Cr | -27.3750 Cr | 94.1150 Cr | 75.4360 Cr | 267.3550 Cr | -28.1760 Cr | 171.0580 Cr | -8.1380 Cr | -11.8600 Cr | -26.0950 Cr |
| 2021-03-31 | 162.8920 Cr | -26.0330 Cr | -26.3100 Cr | 143.3120 Cr | 109.2550 Cr | 191.9190 Cr | -19.5800 Cr | 210.3710 Cr | -11.6860 Cr | -7.9810 Cr | -8.1800 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 171.95 Cr | 92.87 Cr | 79.08 Cr | 0.4599 | 39.14 Cr | 42.50 Cr | 3.80 | 69.07 Cr | 0.2472 |
| 2025-09-30 | 184.53 Cr | 44.57 Cr | 139.96 Cr | 0.7585 | 49.98 Cr | 43.33 Cr | 3.87 | 70.34 Cr | 0.2348 |
| 2025-06-30 | 185.91 Cr | 50.05 Cr | 135.87 Cr | 0.7308 | 46.81 Cr | 39.93 Cr | 3.57 | 65.28 Cr | 0.2148 |
| 2025-03-31 | 167.18 Cr | 93.00 Cr | 74.18 Cr | 0.4437 | 35.53 Cr | 26.48 Cr | 2.36 | 54.35 Cr | 0.1584 |
| 2024-12-31 | 169.11 Cr | 38.83 Cr | 130.28 Cr | 0.7704 | 46.28 Cr | 37.65 Cr | 3.36 | 62.94 Cr | 0.2226 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 62.36 Cr | 556.65 Cr | 619.01 Cr | 125.56 Cr | 173.42 Cr | 933.46 Cr | 315.47 Cr | 1,691.90 Cr | 158.33 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 592.28 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,468.67 Cr |
| 2025-03-31 | 107.69 Cr | 480.26 Cr | 587.94 Cr | 116.21 Cr | 157.31 Cr | 879.87 Cr | 314.63 Cr | 1,621.35 Cr | 152.68 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 506.99 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,388.79 Cr |
| 2024-09-30 | 111.27 Cr | 395.72 Cr | 506.99 Cr | 98.88 Cr | 168.41 Cr | 805.39 Cr | 315.03 Cr | 1,549.18 Cr | 160.40 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 39.93 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 26.48 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 37.65 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 32.83 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 34.15 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2017-05-25 | May 25, 17 | 5:1 |
Similar Stocks: Chemicals - Specialty
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Asian Paints Limited | ASIANPAINT | ₹2,366.40 | ₹2,268,417,572,818.00 | ₹675,590.00 |
| Pidilite Industries Limited | PIDILITIND | ₹1,479.30 | ₹1,505,504,367,538.00 | ₹474,002.00 |
| Solar Industries India Limited | SOLARINDS | ₹13,043.00 | ₹1,180,261,787,365.00 | ₹90,617.00 |
| SRF Limited | SRF | ₹2,833.40 | ₹839,890,099,155.00 | ₹196,550.00 |
| Linde India Limited | LINDEINDIA | ₹6,900.00 | ₹588,461,138,700.00 | ₹404,279.00 |
| Berger Paints India Limited | BERGEPAINT | ₹462.00 | ₹538,676,407,500.00 | ₹309,239.00 |
| Himadri Speciality Chemical Limited | HSCL | ₹450.35 | ₹227,199,323,250.00 | ₹585,694.00 |
| Atul Ltd | ATUL | ₹6,634.50 | ₹195,331,323,548.00 | ₹14,694.00 |
| DCM Shriram Limited | DCMSHRIRAM | ₹1,114.40 | ₹173,781,764,800.00 | ₹19,317.00 |
| Acutaas Chemicals Ltd. | ACUTAAS | ₹2,017.60 | ₹165,183,175,747.00 | ₹308,893.00 |
| Aarti Industries Limited | AARTIIND | ₹446.40 | ₹161,861,961,600.00 | ₹738,891.00 |
| Kansai Nerolac Paints Limited | KANSAINER | ₹200.03 | ₹161,728,455,630.00 | ₹552,584.00 |
| BASF India Limited | BASF | ₹3,653.60 | ₹158,148,414,304.00 | ₹51,310.00 |
| Vinati Organics Limited | VINATIORGA | ₹1,498.70 | ₹155,363,682,678.00 | ₹14,383.00 |
| Anupam Rasayan India Limited | ANURAS | ₹1,336.40 | ₹152,146,467,200.00 | ₹183,391.00 |
| Fine Organic Industries Limited | FINEORG | ₹4,422.90 | ₹135,606,007,850.00 | ₹20,926.00 |
| Akzo Nobel India Limited | AKZOINDIA | ₹2,950.90 | ₹134,384,912,583.00 | ₹28,914.00 |
| Aether Industries Limited | AETHER | ₹966.90 | ₹128,266,372,377.00 | ₹91,324.00 |
| PCBL Limited | PCBL | ₹301.20 | ₹118,510,936,325.00 | ₹1,546,028.00 |
| Privi Speciality Chemicals Limited | PRIVISCL | ₹2,738.00 | ₹106,953,689,028.00 | ₹111,262.00 |
| Garware Hi-Tech Films Limited | GRWRHITECH | ₹4,224.70 | ₹98,149,894,932.00 | ₹82,117.00 |
| Ami Organics Limited | AMIORG | ₹1,176.30 | ₹96,302,382,365.00 | ₹242,994.00 |
| Clean Science and Technology Limited | CLEAN | ₹755.55 | ₹80,296,831,800.00 | ₹403,697.00 |
| Alkyl Amines Chemicals Limited | ALKYLAMINE | ₹1,522.90 | ₹77,887,197,600.00 | ₹24,539.00 |
| Sudarshan Chemical Industries Limited | SUDARSCHEM | ₹924.70 | ₹72,692,423,930.00 | ₹357,480.00 |
| Galaxy Surfactants Limited | GALAXYSURF | ₹1,833.00 | ₹64,988,560,416.00 | ₹7,613.00 |
| Kingfa Science & Technology (India) Limited | KINGFA | ₹4,304.30 | ₹58,329,209,238.00 | ₹2,805.00 |
| Gulf Oil Lubricants India Limited | GULFOILLUB | ₹1,124.30 | ₹55,540,503,198.00 | ₹37,121.00 |
| Responsive Industries Limited | RESPONIND | ₹189.24 | ₹50,453,000,867.00 | ₹137,461.00 |
| Indigo Paints Limited | INDIGOPNTS | ₹973.10 | ₹46,393,186,692.00 | ₹86,792.00 |
| Laxmi Organic Industries Limited | LXCHEM | ₹146.74 | ₹40,668,678,884.00 | ₹271,645.00 |
| Pondy Oxides And Chemicals Limited | POCL | ₹1,192.40 | ₹36,381,649,080.00 | ₹124,240.00 |
| Balaji Amines Limited | BALAMINES | ₹1,079.10 | ₹34,963,919,100.00 | ₹78,472.00 |
| Vishnu Chemicals Limited | VISHNU | ₹515.15 | ₹34,677,468,553.00 | ₹63,857.00 |
| Neogen Chemicals Limited | NEOGEN | ₹1,286.40 | ₹33,937,385,434.00 | ₹22,237.00 |
| Advanced Enzyme Technologies Limited | ADVENZYMES | ₹300.95 | ₹33,684,370,460.00 | ₹68,058.00 |
| Camlin Fine Sciences Limited | CAMLINFINE | ₹165.98 | ₹31,882,536,026.00 | ₹461,300.00 |
| Prince Pipes and Fittings Limited | PRINCEPIPE | ₹266.07 | ₹29,416,986,290.00 | ₹109,452.00 |
| Grauer & Weil (India) Limited | GRAUWEIL | ₹117.90 | ₹29,075,437,490.00 | ₹464,402.00 |
| Rossari Biotech Limited | ROSSARI | ₹524.25 | ₹29,034,729,626.00 | ₹24,931.00 |
| Ddev Plastiks Industries Ltd. | DDEVPLSTIK | ₹280.00 | ₹28,973,465,920.00 | ₹62,821.00 |
| Jubilant Agri and Consumer Products Ltd. | JUBLCPL | ₹1,896.30 | ₹28,733,672,476.00 | ₹10,049.00 |
| Tatva Chintan Pharma Chem Limited | TATVA | ₹1,197.20 | ₹28,004,968,246.00 | ₹85,203.00 |
| Kiri Industries Limited | KIRIINDUS | ₹457.75 | ₹27,475,324,094.00 | ₹557,699.00 |
Key Executives
MD & Head of Research and Development - evoxx technologies GmbH
Michael Puls
Gender: Not Specified
Year Born:
Chief Financial Officer
Beni Prasad Rauka
Gender: male
Year Born: 1964
General Manager of Human Resources & Administration
Bhaskar Manolkar
Gender: male
Year Born: 1959
Senior Vice President of Marketing & Business Development
Dipak Roda
Gender: male
Year Born: 1973
Chief Financial Officer & Chief Operating Officer of US Subsidiaries
Harshad Doshi
Gender: male
Year Born:
Investor Relations Manager
Ronak Saraf
Gender: male
Year Born:
Company Secretary, Head of Legal & Compliance Officer
Sanjay Prakash Basantani
Gender: male
Year Born:
Plant Manager & Head of Operations - Sinnar
Satish Pagar
Gender: male
Year Born:
MD & Head of Business Development - evoxx technologies GmbH
Martina Doering
Gender: female
Year Born:
FAQs about Advanced Enzyme Technologies Limited
Who is the CEO of the company?
The CEO is Beni Prasad Rauka.
What is the current market price of the stock?
The current price is ₹300.95.
What is the 52-week price range?
The range is ₹257.9-366.25.
What is the market capitalization of the company?
The market capitalization is ₹3,368.44 crores.
What is the dividend yield?
The dividend yield is 1.73%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 22.13.
Which sector does the company belong to?
The company operates in the Basic Materials sector.
What does the company do?
Overview of Advanced Enzyme Technologies Limited (ISIN: INE837H01020) is a leading Chemicals - Specialty in India. With a market capitalization of ₹3,368.44 crores and an average daily volume of 146,212 shares, it operates in the Chemicals - Specialty. The company last declared a dividend of ₹5.2.